Tag: Clinical
-
Pharmacology Expert Allowed to Opine on the Clinical Trial
Alzamend Neuro, Inc is a clinical-stage biopharmaceutical company focused on developing treatments for Alzheimer’s disease and other neurodegenerative diseases. To advance the development of a new treatment called ALZN002, Alzamend sought to conduct a phase I/IIA clinical trial to evaluate its safety, tolerability, and preliminary efficacy. Biorasi, LLC is a contract research organization or clinical…
-
Social Work Expert’s Testimony on Gender Identity Admitted
Plaintiffs Elizabeth Mirabelli, Lori Ann West, and others brought this action on behalf of themselves and a putative class challenging school district policies regarding the social transition of students who identify as transgender. The central dispute concerns whether California’s public school teachers and staff may notify parents when a student uses a different name or…
-
Immunology Expert Witness’ Redevelopment Opinion Excluded
Plaintiff I-Mab Biopharma (“I-Mab” or “Plaintiff”) brought trade secret misappropriation claims against Defendants Inhibrx, Inc. (“Inhibrx”) and Brendan Eckelman (“Dr. Eckelman” and collectively with Inhibrx, “Defendants”). Plaintiff asserted that Defendants misappropriated nine trade secrets (that correspond to molecules designed to treat cancer) that are referred to herein as Trade Secret 1, Trade Secret 2, Trade…
